SecBot SecBot

Affordable Insulin Now Act

H.R. 1488 Rep. Angie Craig (D-MN-2) In committee
  1. Introduced Mar 9
  2. Committee Mar 9
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Mar 9, 2023Next: House vote
680d ago Dec 17, 2024: Referred to the Subcommittee on Health.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
2companies, 2 filings
Member trades
4trades in the last 90 days
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

2 companies
Companies by sector
Biotech & Pharma 1Financials 1
Search all 2 companies, their asks and price moves Subscribe

Summary

Affordable Insulin Now Act

Full summary2 paragraphs

This bill limits cost-sharing for insulin under private health insurance.

Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2024.

Library of Congress summary, Mar 9, 2023

Summary versions
  • Introduced in HouseMar 9, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.